Acrivon Therapeutics (ACRV) Shares Outstanding (Diluted) (2021 - 2026)
Acrivon Therapeutics (ACRV) reported Shares Outstanding (Diluted) of 41.84 million for Q2 2026, up 8.8% from 38.46 million a year earlier and up 8.0% from the prior quarter.
Powered by 
Analysis
Acrivon Therapeutics (ACRV) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends
For FY2025, Acrivon Therapeutics posted Shares Outstanding (Diluted) of 38.51 million, up 14.0% from FY2024.
- Shares Outstanding (Diluted) has increased for four consecutive years, with a four-year compound annual growth rate of 116.8% (FY2021 to FY2025).
- By year, Shares Outstanding (Diluted) came in at 33.79 million in FY2024 (+53.1%), 22.08 million in FY2023 (+435.6%), 4.12 million in FY2022 (+136.4%) and 1.74 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Shares Outstanding (Diluted) in data going back to Q3 2021.
- Year over year, Shares Outstanding (Diluted) has now increased in each of the last 11 quarters, with growth averaging 28.3% over the last eight quarters.
- Across the past five years, year-over-year growth in Shares Outstanding (Diluted) ran from 0.5% in Q3 2022 to 435.6% in Q4 2023.
- Per Business Quant data, the three quarters before Q2 2026 came in at 38.72 million (Q1 2026), 38.51 million (Q4 2025) and 38.56 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 893.70 Mn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 2.44 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 1.56 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 544.00 Mn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Acrivon Therapeutics | 86.12 Mn | 86.12 Mn | - | 41.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 41.84 Mn |
| Mar 31, 2026 | 38.72 Mn |
| Dec 31, 2025 | 38.51 Mn |
| Sep 30, 2025 | 38.56 Mn |
| Jun 30, 2025 | 38.46 Mn |
| Mar 31, 2025 | 38.35 Mn |
| Dec 31, 2024 | 33.79 Mn |
| Sep 30, 2024 | 38.11 Mn |
| Jun 30, 2024 | 36.13 Mn |
| Mar 31, 2024 | 22.59 Mn |
| Dec 31, 2023 | 22.08 Mn |
| Sep 30, 2023 | 22.08 Mn |
| Jun 30, 2023 | 21.97 Mn |
| Mar 31, 2023 | 21.92 Mn |
| Dec 31, 2022 | 4.12 Mn |
| Sep 30, 2022 | 1.78 Mn |
| Jun 30, 2022 | 1.77 Mn |
| Mar 31, 2022 | 1.77 Mn |
| Dec 31, 2021 | 1.74 Mn |
| Sep 30, 2021 | 1.77 Mn |
API Access
Acrivon Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=ACRV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "ACRV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=ACRV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();